Riskpilot← Back to searchSign inGet full accessRecordis AB
ABActiveOrg 5591663298Järntorget 83Research and experimental development on natural sciences and engineering · NACE 7210Est. 20181 employees
Revenue 2024
SEK 374K
-35% vs 2023
EBITDA margin
73.0%
0% vs 2023
Equity ratio
69.5%
Financial strength
Net profit 2024
SEK 226K
+1% vs 2023
| Revenue | SEK 374K | -35% |
| EBITDA | SEK 273K | +0% |
| Net profit | SEK 226K | +1% |
| Total assets | SEK 756K | -4% |
| Equity | SEK 526K | +0% |
| Employees | 1 | — |
Legal name
Recordis AB
Org number
5591663298
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18 juli 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet samt egen verksamhet inom onkologi, läkemedelsutveckling, bioteknologi, kommersialisering av läkemedel. Utveckling och utvärdering av AI inom läkemedelsutveckling, biologi men även kreativt skapande inklusive litteratur och komposition.
Address
Järntorget 83
Email
christer.svedman@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 780 | 1 930 | 696 | 578 | 374 |
| Staff expenses | — | — | −65 | −25 | −7 |
| EBITDA | 757 | 1 316 | 334 | 273 | 273 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 757 | 1 316 | 334 | 273 | 273 |
| Net financials | 6 | −49 | −1 | 9 | 10 |
| Profit before tax | 763 | 1 360 | 333 | 281 | 283 |
| Tax | −163 | −281 | −71 | −57 | −57 |
| Net profit | 600 | 1 079 | 262 | 224 | 226 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 574 | 1 677 | 562 | 787 | 756 |
| Equity | 900 | 1 379 | 562 | 524 | 526 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 674 | 299 | 0 | 262 | 230 |
| Total debt | 674 | 299 | — | 262 | 230 |
EBITDA margin
73.0%
This company
15.8%
Market median
+362% vs market
20202024
Equity ratio
69.5%
This company
38.2%
Market median
+82% vs market
20202024
Return on equity
42.9%
This company
18.4%
Market median
+133% vs market
20202024
Net profit margin
60.4%
This company
8.1%
Market median
+646% vs market
20202024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20202024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CS Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Epitope AB
Recordis AB Board members of Recordis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christer Svedman | Chief Executive Officer | 0 companies |
| Agnes Birgitta Svedman | Deputy Board Member | 0 companies |